4.7 Article

Passive transfer of narcolepsy: Anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice

期刊

JOURNAL OF AUTOIMMUNITY
卷 45, 期 -, 页码 24-30

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jaut.2013.06.010

关键词

Narcolepsy; Anti-Tribbles homolog 2 (TRIB2) antibodies; Passive transfer; Orexin; Behavioral deficits

资金

  1. Federico Foundation
  2. Grants-in-Aid for Scientific Research [22133008] Funding Source: KAKEN

向作者/读者索取更多资源

Narcolepsy is a sleep disorder characterized by excessive daytime sleepiness and cataplexy (a sudden weakening of posture muscle tone usually triggered by emotion) caused by the loss of orexin neurons in the hypothalamus. Autoimmune mechanisms are implicated in narcolepsy by increased frequency of specific HLA alleles and the presence of specific autoantibody (anti-Tribbles homolog 2 (TRIB2) antibodies) in the sera of patients with narcolepsy. Presently, we passively transferred narcolepsy to naive mice by injecting intra-cerebra-ventricularly (ICV) pooled IgG positive for anti-TRIB2 antibodies. Narcolepsy-IgG-injected mice had a loss of the NeuN (neuronal marker), synaptophysin (synaptic marker) and orexin-positive neurons in the lateral hypothalamus area in narcolepsy compared to control-IgG-injected mice and these changes were associated with narcolepsy-like immobility attacks at four weeks post injection and with hyperactivity and long term memory deficits in the staircase and novel object recognition tests. Similar behavioral and cognitive deficits are observed in narcoleptic patients. This is the first report of passive transfer of experimental narcolepsy to naive mice induced by autoantibodies and supports the autoimmune pathogenesis in narcolepsy. (C) 2013 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Intrinsic Expression of Coagulation Factors and Protease Activated Receptor 1 (PAR1) in Photoreceptors and Inner Retinal Layers

Zehavit Goldberg, Ifat Sher, Lamis Qassim, Joab Chapman, Ygal Rotenstreich, Efrat Shavit-Stein

Summary: This study characterized the distribution of thrombin receptor PAR1 in the neuroretina and suggested a potential role of the thrombin pathway in retinal function.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jeremy Manry, Paul Bastard, Adrian Gervais, Tom Le Voyer, Jeremie Rosain, Quentin Philippot, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Shohei Eto, Marina Garcia-Prat, Lucy Bizien, Alba Parra-Martinez, Rui Yang, Liis Haljasmagi, Melanie Migaud, Karita Sarekannu, Julia Maslovskaja, Nicolas de Prost, Yacine Tandjaoui-Lambiotte, Charles-Edouard Luyt, Blanca Amador-Borrero, Alexandre Gaudet, Julien Poissy, Pascal Morel, Pascale Richard, Fabrice Cognasse, Jesus Troya, Sophie Trouillet-Assant, Alexandre Belot, Kahina Saker, Pierre Garcon, Jacques G. Riviere, Jean-Christophe Lagier, Stephanie Gentile, Lindsey B. Rosen, Elana Shaw, Tomohiro Morio, Junko Tanaka, David Dalmau, Pierre-Louis Tharaux, Damien Sene, Alain Stepanian, Bruno Megarbane, Vasiliki Triantafyllia, Arnaud Fekkar, James R. Heath, Jose Luis Franco, Juan-Manuel Anaya, Jordi Sole-Violan, Luisa Imberti, Andrea Biondi, Paolo Bonfanti, Riccardo Castagnoli, Ottavia M. Delmonte, Yu Zhang, Andrew L. Snow, Steven M. Holland, Catherine M. Biggs, Marcela Moncada-Velez, Andres Augusto Arias, Lazaro Lorenzo, Soraya Boucherit, Dany Anglicheau, Anna M. Planas, Filomeen Haerynck, Sotirija Duvlis, Tayfun Ozcelik, Sevgi Keles, Ahmed A. Bousfiha, Jalila El Bakkouri, Carolina Ramirez-Santana, Stephane Paul, Qiang Pan-Hammarstrom, Lennart Hammarstrom, Annabelle Dupont, Alina Kurolap, Christine N. Metz, Alessandro Aiuti, Giorgio Casari, Vito Lampasona, Fabio Ciceri, Lucila A. Barreiros, Elena Dominguez-Garrido, Mateus Vidigal, Mayana Zatz, Diederik van de Beek, Sabina Sahanic, Ivan Tancevski, Yurii Stepanovskyy, Oksana Boyarchuk, Yoko Nukui, Miyuki Tsumura, Loreto Vidaur, Stuart G. Tangye, Sonia Burrel, Darragh Duffy, Lluis Quintana-Murci, Adam Klocperk, Nelli Y. Kann, Anna Shcherbina, Yu-Lung Lau, Daniel Leung, Matthieu Coulongeat, Julien Marlet, Rutger Koning, Luis Felipe Reyes, Angelique Chauvineau-Grenier, Fabienne Venet, Guillaume Monneret, Michel C. Nussenzweig, Romain Arrestier, Idris Boudhabhay, Hagit Baris-Feldman, David Hagin, Joost Wauters, Isabelle Meyts, Adam H. Dyer, Sean Kennelly, Nollaig M. Bourkeh, Rabih Halwan, Fatemeh Saheb Sharif-Askar, Karim Dorgham, Jerome Sallette, Souad Mehlal Sedkaoui, Suzan AlKhater, Raul Rigo-Bonnin, Francisco Morandeira, Lucie Roussel, Donald C. Vinh, Christian Erikstrup, Antonio Condino-Neto, Carolina Prando, Anastasiia Bondarenko, Andras N. Spaan, Laurent Gilardin, Jacques Fellay, Stanislas Lyonnet, Kaya Bilguvar, Richard P. Lifton, Shrikant Mane, Mark S. Anderson, Bertrand Boisson, Vivien Beziat, Shen-Ying Zhang, Evangelos Andreakos, Olivier Hermine, Aurora Pujol, Part Peterson, Trine H. Mogensen, Lee Rowen, James Mond, Stephanie Debette, Xavier de Lamballerie, Charles Burdet, Lila Bouadma, Marie Zins, Pere Soler-Palacin, Roger Colobran, Guy Gorochov, Xavier Solanich, Sophie Susen, Javier Martinez-Picado, Didier Raoult, Marc Vasse, Peter K. Gregersen, Lorenzo Piemonti, Carlos Rodriguez-Gallego, Luigi D Notarangelo, Helen C. Su, Kai Kisand, Satoshi Okada, Anne Puel, Emmanuelle Jouanguy, Charles M. Rice, Pierre Tiberghien, Qian Zhang, Jean-Laurent Casanova, Laurent Abel, Aurelie Cobat

Summary: This study investigates the impact of autoimmunity on COVID-19-related deaths and finds that individuals carrying autoantibodies neutralizing type I interferons are at higher risk of death, with the risk decreasing with age.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Infectious Diseases

Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study

Manuel Rojas, Yhojan Rodriguez, Juan Carlos Hernandez, Juan C. Diaz-Coronado, Jose Alejandro Daza Vergara, Veronica Posada Velez, Jessica Porras Mancilla, Ivan Araujo, Jairo Torres Yepes, Oscar Briceno Ricaurte, Juan Mauricio Pardo-Oviedo, Diana M. Monsalve, Yeny Acosta-Ampudia, Carolina Ramirez-Santana, Paula Gaviria Garcia, Lina Acevedo Landinez, Luisa Duarte Correales, Jeser Santiago Grass, Cristian Ricaurte Perez, Gustavo Salguero Lopez, Nataly Mateus, Laura Mancera, Ronald Rengifo Devia, Juan Esteban Orjuela, Christian R. Parra-Moreno, Andres Alfonso Buitrago, Ines Elvira Ordonez, Claudia Fabra Osorio, Nathalia Ballesteros, Luz H. Patino, Sergio Castaneda, Marina Munoz, Juan David Ramirez, Paul Bastard, Adrian Gervais, Lucy Bizien, Jean-Laurent Casanova, Bernardo Camacho, Juan Esteban Gallo, Oscar Gomez, Adriana Rojas-Villarraga, Carlos E. Perez, Ruben Manrique, Ruben D. Mantilla, Juan-Manuel Anaya

Summary: The use of convalescent plasma (CP) in the early stages of COVID-19 did not lead to a reduction in viral load, but it was found to be safe and may reduce hospital stay.

BMC INFECTIOUS DISEASES (2022)

Article Immunology

Is post-COVID syndrome an autoimmune disease?

Juan-Manuel Anaya, Maria Herran, Santiago Beltran, Manuel Rojas

Summary: This article introduces the post-COVID syndrome (PCS) and its mechanisms related to autoimmunity. The author emphasizes the importance of defining and classifying PCS, and suggests the need for longitudinal and controlled studies to better understand PCS. It is also noted that with the increasing prevalence of COVID-19 cases, there may be an increase in autoimmune diseases.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Genome-wide association study identifies Sjogren's risk loci with functional implications in immune and glandular cells

Bhuwan Khatri, Kandice L. Tessneer, Astrid Rasmussen, Farhang Aghakhanian, Tove Ragna Reksten, Adam Adler, Ilias Alevizos, Juan-Manuel Anaya, Lara A. Aqrawi, Eva Baecklund, Johan G. Brun, Sara Magnusson Bucher, Maija-Leena Eloranta, Fiona Engelke, Helena Forsblad-d'Elia, Stuart B. Glenn, Daniel Hammenfors, Juliana Imgenberg-Kreuz, Janicke Liaaen Jensen, Svein Joar Auglaend Johnsen, Malin Jonsson, Marika Kvarnstrom, Jennifer A. Kelly, He Li, Thomas Mandl, Javier Martin, Gaetane Nocturne, Katrine Braekke Norheim, Oyvind Palm, Kathrine Skarstein, Anna M. Stolarczyk, Kimberly E. Taylor, Maria Teruel, Elke Theander, Swamy Venuturupalli, Daniel J. Wallace, Kiely M. Grundahl, Kimberly S. Hefner, Lida Radfar, David M. Lewis, Donald U. Stone, C. Erick Kaufman, Michael T. Brennan, Joel M. Guthridge, Judith A. James, R. Hal Scofield, Patrick M. Gaffney, Lindsey A. Criswell, Roland Jonsson, Per Eriksson, Simon J. Bowman, Roald Omdal, Lars Ronnblom, Blake Warner, Maureen Rischmueller, Torsten Witte, A. Darise Farris, Xavier Mariette, Marta E. Alarcon-Riquelme, Caroline H. Shiboski, Marie Wahren-Herlenius, Wan-Fai Ng, Kathy L. Sivils, Indra Adrianto, Gunnel Nordmark, Christopher J. Lessard

Summary: This study identifies ten novel genetic risk regions associated with Sjogren's disease, implicating genes involved in immune and salivary gland function.

NATURE COMMUNICATIONS (2022)

Review Immunology

Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review

Yhojan Rodriguez, Manuel Rojas, Santiago Beltran, Fernando Polo, Laura Camacho-Dominguez, Samuel David Morales, M. Eric Gershwin, Juan-Manuel Anaya

Summary: This study suggests a potential association between COVID-19 vaccination and autoimmune and inflammatory diseases. New-onset conditions were more common, with immune thrombocytopenia, myocarditis, and Guillain-Barre syndrome being the most common diseases associated with new-onset events. Some diseases may relapse after vaccination. Further large-scale studies are needed to validate this relationship.

JOURNAL OF AUTOIMMUNITY (2022)

Correction Multidisciplinary Sciences

Genome-wide association study identifies Sjogren's risk loci with functional implications in immune and glandular cells (vol 13, 4287, 2022)

Bhuwan Khatri, Kandice L. Tessneer, Astrid Rasmussen, Farhang Aghakhanian, Tove Ragna Reksten, Adam Adler, Ilias Alevizos, Juan-Manuel Anaya, Lara A. Aqrawi, Eva Baecklund, Johan G. Brun, Sara Magnusson Bucher, Maija-Leena Eloranta, Fiona Engelke, Helena Forsblad-d'Elia, Stuart B. Glenn, Daniel Hammenfors, Juliana Imgenberg-Kreuz, Janicke Liaaen Jensen, Svein Joar Auglaend Johnsen, Malin V. Jonsson, Marika Kvarnstrom, Jennifer A. Kelly, He Li, Thomas Mandl, Javier Martin, Gaetane Nocturne, Katrine Braekke Norheim, Oyvind Palm, Kathrine Skarstein, Anna M. Stolarczyk, Kimberly E. Taylor, Maria Teruel, Elke Theander, Swamy Venuturupalli, Daniel J. Wallace, Kiely M. Grundahl, Kimberly S. Hefner, Lida Radfar, David M. Lewis, Donald U. Stone, C. Erick Kaufman, Michael T. Brennan, Joel M. Guthridge, Judith A. James, R. Hal Scofield, Patrick M. Gaffney, Lindsey A. Criswell, Roland Jonsson, Per Eriksson, Simon J. Bowman, Roald Omdal, Lars Ronnblom, Blake Warner, Maureen Rischmueller, Torsten Witte, A. Darise Farris, Xavier Mariette, Marta E. Alarcon-Riquelme, Caroline H. Shiboski, Marie Wahren-Herlenius, Wan-Fai Ng, Kathy L. Sivils, Indra Adrianto, Gunnel Nordmark, Christopher J. Lessard

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

OLIG2 is an in vivo bookmarking transcription factor in the developing neural tube in mouse

Shinichi Hayashi, Souichi Oe, Taro Koike, Ryohei Seki-Omura, Yosuke Nakano, Yukie Hirahara, Susumu Tanaka, Takeshi Ito, Yoshiki Yasukochi, Koichiro Higasa, Masaaki Kitada

Summary: Cells possess inheritable features that maintain a unique gene expression pattern and contribute to cellular memory. Some transcription factors, including OLIG2, can be retained in mitotic chromosomes and participate in cellular memory. In the neural tube of mouse embryos, OLIG2 binds to chromatin through every cell cycle, indicating its role as an in vivo bookmarking transcription factor.

JOURNAL OF NEUROCHEMISTRY (2023)

Correction Multidisciplinary Sciences

Genome-wide association study identifies Sjogren's risk loci with functional implications in immune and glandular cells (vol 13, 4287, 2022)

Bhuwan Khatri, Kandice Tessneer, Astrid Rasmussen, Farhang Aghakhanian, Tove Ragna Reksten, Adam A. Adler, Ilias Alevizos, Juan-Manuel G. Anaya, Lara Aqrawi, Eva Baecklund, Johan Brun, Sara Magnusson Bucher, Maija-Leena B. Eloranta, Fiona Engelke, Helena Forsblad-d'Elia, Stuart Glenn, Daniel Hammenfors, Juliana V. Imgenberg-Kreuz, Janicke Liaaen Jensen, Svein Joar Auglaend A. Johnsen, Malin Jonsson, Marika Kvarnstroem, Jennifer Kelly, He Li, Thomas Mandl, Javier Martin, Gaetane Nocturne, Katrine Braekke M. Norheim, Oyvind E. Palm, Kathrine Skarstein, Anna Stolarczyk, Kimberly Taylor, Maria J. Teruel, Elke M. Theander, Swamy S. Venuturupalli, Daniel Wallace, Kiely M. Grundahl, Kimberly U. Hefner, Lida Radfar, David T. Lewis, Donald M. Stone, C. Erick A. Kaufman, Michael Brennan, Joel M. Guthridge, Judith A. James, R. Hal Scofield, Patrick Gaffney, Lindsey J. Criswell, Roland Jonsson, Per Eriksson, Simon Bowman, Roald Omdal, Lars Roennblom, Blake Warner, Maureen Rischmueller, Torsten E. Witte, A. Darise H. Farris, Xavier Mariette, Marta Alarcon-Riquelme, Caroline L. Shiboski, Marie Wahren-Herlenius, Wan-Fai Ng, Kathy J. Sivils, Indra Adrianto, Gunnel Nordmark, Christopher Lessard

NATURE COMMUNICATIONS (2023)

Article Clinical Neurology

Guillain-Barre Syndrome Following Zika Virus Infection Is Associated With a Diverse Spectrum of Peripheral Nerve Reactive Antibodies

Alexander J. Davies, Cinta Lleixa, Ana M. Siles, Dawn S. Gourlay, Georgina Berridge, Wanwisa Dejnirattisai, Carolina Ramirez-Santana, Juan-Manuel Anaya, Andrew K. Falconar, Claudia M. Romero-Vivas, Lyda Osorio, Beatriz Parra, Gavin R. Screaton, Juthathip Mongkolsapaya, Roman Fischer, Carlos A. Pardo, Susan K. Halstead, Hugh J. Willison, Luis Querol, Simon Rinaldi

Summary: By screening the sera of patients with Zika virus (ZIKV) with and without Guillain-Barre syndrome (GBS), researchers discovered the presence of autoantibodies targeting peripheral nerves. This suggests that Zika virus infection may lead to immune-mediated neurologic symptoms.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2023)

Review Virology

Post-COVID Syndrome in Adults-An Overview

Ruediger E. Scharf, Juan-Manuel Anaya

Summary: This article provides an overview of various aspects related to post-COVID syndrome, including its prevalence, symptoms and sequelae, risk determinants, and psychosocial implications. It also discusses the pathogenesis of post-COVID condition, focusing on thrombo-inflammation, neutrophil extracellular traps, and venous thromboembolism. Additionally, it reviews COVID-19 and post-COVID syndrome in immunocompromising conditions, and the impact of vaccination on the prevention and treatment of post-COVID symptoms. The article highlights autoimmunity as a hallmark of post-COVID syndrome and the potential increase of autoimmune disorders globally.

VIRUSES-BASEL (2023)

Meeting Abstract Critical Care Medicine

MORTALITY AND CLINICAL CHARACTERISTICS OF MULTISYSTEMIC INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) ASSOCIATED WITH COVID-19 IN CRITICALLY ILL PATIENTS IN A MIDDLE-INCOME COUNTRY: OBSERVATIONAL MULTICENTER STUDY

L. Acevedo, B. E. Pineres, L. F. Nino, L. Mazzillo, I. J. Ardila, S. Chacon, J. C. Jaramillo, H. Mulett, O. Gonzalez, E. Zemanate, L. Izquierdo, J. Rojas, J. Piracoca, J. L. Junco, B. Giraldo, C. Bonilla, H. Preciado, R. Orozco, M. Alvarez, C. Giraldo, J. C. Salazar, J. M. Anaya

PEDIATRIC CRITICAL CARE MEDICINE (2022)

Article Biochemistry & Molecular Biology

LPS-Induced Coagulation and Neuronal Damage in a Mice Model Is Attenuated by Enoxaparin

Shani Berkowitz, Shany Guly Gofrit, Shay Anat Aharoni, Valery Golderman, Lamis Qassim, Zehavit Goldberg, Amir Dori, Nicola Maggio, Joab Chapman, Efrat Shavit-Stein

Summary: The study found that there is an interaction between neuroinflammation and coagulation, and enoxaparin can protect against inflammation induced by LPS, reducing neuronal damage. The findings may provide a new pharmacological mechanism for intervening in neuroinflammation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Immunology

COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature

Laura Camacho-Dominguez, Yhojan Rodriguez, Fernando Polo, Juan Carlos Restrepo Gutierrez, Elizabeth Zapata, Manuel Rojas, Juan-Manuel Anaya

Summary: This report presents a case of a 79-year-old man who developed autoimmune hepatitis type 1 after receiving the ChAdOx1 nCoV-19 vaccine. Clinical symptoms improved rapidly after immunomodulatory treatment was initiated. This case, along with a comprehensive literature review, highlights the association between COVID-19 vaccines and the development of autoimmune conditions.

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2022)

Review Biochemistry & Molecular Biology

Familial Hyperaldosteronism Type 3 with a Rapidly Growing Adrenal Tumor: An In Situ Aldosterone Imaging Study

Nae Takizawa, Susumu Tanaka, Koshiro Nishimoto, Yuki Sugiura, Makoto Suematsu, Chisato Ohe, Haruyuki Ohsugi, Yosuke Mizuno, Kuniaki Mukai, Tsugio Seki, Kenji Oki, Celso E. Gomez-Sanchez, Tadashi Matsuda

Summary: This study presents an unusual case of familial hyperaldosteronism type 3 (FH3) in a young woman who was first diagnosed with primary aldosteronism at the age of 6 years. Despite undergoing unilateral adrenalectomy to alleviate hyperaldosteronism, the hyperaldosteronism persisted. At the age of 26 years, additional adrenal tumors were discovered and removed. Histological, immunohistochemical, and molecular evaluation of the tumors and adrenal gland showed the presence of aldosterone synthase (CYP11B2) immunoreactivity, as well as a somatic beta-catenin activating mutation in the larger tumor. In situ visualization of aldosterone also revealed its presence only in the subcapsular regions of the adrenal gland and not in the tumors.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2022)

Article Immunology

Isolation and characterisation of PR3-specific B cells and their immunoglobulin sequences

Shane Kelly, Katherine J. L. Jackson, Timothy J. Peters, Dan Suan, Christopher C. Goodnow

Summary: This study successfully identified and characterized PR3-specific B cells from the peripheral blood of patients with PR3 autoantibodies. These cells exhibited specific immunological features, suggesting that PR3 self-reactivity may occur early in B-cell development.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

Targeting NF-κB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis

Ana Merino-Vico, Jan Piet van Hamburg, Paul Tuijnenburg, Giulia Frazzei, Aram Al-Soudi, Carlo G. Bonasia, Boy Helder, Abraham Rutgers, Wayel H. Abdulahad, Coen A. Stegeman, Jan-Stephan Sanders, Laura Bergamaschi, Paul A. Lyons, Theo Bijma, Laura van Keep, Kirsten Wesenhagen, Aldo Jongejan, Henric Olsson, Niek de Vries, Taco W. Kuijpers, Peter Heeringa, Sander W. Tas

Summary: B lineage cells play a critical role in ANCA-associated vasculitis (AAV), and the transcription factor NF-kappa B may be a potential therapeutic target for AAV and other autoimmune diseases with prominent B cell involvement.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

K2P2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathies

Christopher Nelke, Thomas Muentefering, Derya Cengiz, Lukas Theissen, Vera Dobelmann, Christina B. Schroeter, Helena Block, Corinna Preu, Alexander P. E. Michels, Stefanie Lichtenberg, Marc Pawlitzki, Steffen Pfeuffer, Niklas Huntemann, Alexander Zarbock, Thorben Briese, Christoph Kittl, Carsten Dittmayer, Thomas Budde, Ingrid E. Lundberg, Werner Stenzel, Sven G. Meuth, Tobias Ruck

Summary: K2P2.1 plays a regulatory role in the autoimmune response of idiopathic inflammatory myopathies (IIMs), by regulating inflammatory cell response, adhesion, and transmigration in both endothelial and skeletal muscle cells. Inhibiting K2P2.1 enhances the inflammatory response, while activating K2P2.1 improves the disease course.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis

Xuan Zhang, Jun Xia, Ying Jiang, David S. Pisetsky, Josef S. Smolen, Rong Mu, Shengming Dai, Michael E. Weinblatt, Tore K. Kvien, Juan Li, Thomas Doerner, Yu Zhang, Liwei Lu, Chengde Yang, Pingting Yang, Yuan Zhang, Chenchen Xu, Zhan Zhao, Peter E. Lipsky

Summary: The study suggests that TwHF may be as effective as MTX in treating active RA, and combination therapy may be more effective than monotherapy.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

Novel and unique rheumatoid factors cross-react with viral epitopes in COVID-19

Maya F. Amjadi, Maxwell H. Parker, Ryan R. Adyniec, Zihao Zheng, Alex M. Robbins, S. Janna Bashar, Michael F. Denny, Sara S. Mccoy, Irene M. Ong, Miriam A. Shelef

Summary: Rheumatoid factors (RFs) are polyreactive antibodies that can bind disease-specific epitopes. Recent studies have found that RFs in COVID-19 can bind novel IgG epitopes, which provides new insights into the mechanism of RFs.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study

Johanne Liberatore, Yann Nguyen, Jerome Hadjadj, Pascal Cohen, Luc Mouthon, Xavier Puechal, Loic Guillevin, Benjamin Terrier

Summary: B-cell depletion induced by rituximab (RTX) in ANCA-associated vasculitis (AAV) can lead to decreased gammaglobulin levels, which is associated with an increased risk of relapse and severe infections. Older age, low gammaglobulin levels, and receiving pulses of methylprednisolone at induction therapy are risk factors for gammaglobulin decline.

JOURNAL OF AUTOIMMUNITY (2024)